Skip to main content
. 2016 Jun 23;11(6):e0158307. doi: 10.1371/journal.pone.0158307

Fig 2. Kaplan–Meier survival analysis.

Fig 2

a progression-free survival (PFS) and b overall survival (OS) according to whole-body total lesion glycolysis (TLGWBR) determined using the Response Evaluation Criteria In Solid Tumors 1.1 criteria in 176 patients with advanced lung adenocarcinoma. Kaplan–Meier analysis of c PFS and d OS according to TLGWBR in 85 patients with wild-type EGFR. e Kaplan–Meier analysis of PFS and f OS according to TLGWBR in 91 patients with the EGFR mutation.